Literature DB >> 20033752

VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature.

Anca Maria Cimpean1, Edward Seclaman, Raluca Ceauşu, Pusa Gaje, Stefana Feflea, Andrei Anghel, Marius Raica, Domenico Ribatti.   

Abstract

Vascular endothelial growth factor-A (VEGF-A) and hepatocyte growth factor (HGF) are well known angiogenesis inductors and promoters in normal and pathologic conditions. Recent data showed that VEGF-A and HGF could also influence lymphangiogenesis but this matter has not been completely elucidated. Administration of VEGF-A and HGF in combination has been used to improve the angiogenic response in different experimental models, but their effects on lymphangiogenesis have not been investigated. The aim of this study was to characterize blood and lymphatic vascular response to VEGF-A/HGF administration. To this purpose, we built a pBlast VEGF-A/HGF combination suitable for in vivo research. By using as an experimental in vivo model the chick embryo chorioallantoic membrane (CAM) assay, we applied pBlast VEGF-A/HGF combination for 7 days. Results showed that VEGF-A/HGF combination was able to induce a strong angiogenic response and the expression of Prox-1 in the lymphatic endothelial cells of the CAM. The possible mechanisms involved have been speculated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033752     DOI: 10.1007/s10238-009-0085-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  25 in total

1.  Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

Authors:  E Van Belle; B Witzenbichler; D Chen; M Silver; L Chang; R Schwall; J M Isner
Journal:  Circulation       Date:  1998-02-03       Impact factor: 29.690

2.  Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.

Authors:  X Xin; S Yang; G Ingle; C Zlot; L Rangell; J Kowalski; R Schwall; N Ferrara; M E Gerritsen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Prox1 function is required for the development of the murine lymphatic system.

Authors:  J T Wigle; G Oliver
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

4.  Hepatocyte growth factor promotes lymphatic vessel formation and function.

Authors:  Kentaro Kajiya; Satoshi Hirakawa; Beijia Ma; Ines Drinnenberg; Michael Detmar
Journal:  EMBO J       Date:  2005-07-28       Impact factor: 11.598

5.  Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.

Authors:  Jesús Medina; Luis Caveda; Paloma Sanz-Cameno; Alicia G Arroyo; Samuel Martín-Vílchez; Pedro L Majano; Luisa García-Buey; Francisco Sánchez-Madrid; Ricardo Moreno-Otero
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

6.  Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor.

Authors:  E M Rosen; J Knesel; I D Goldberg; L Jin; M Bhargava; A Joseph; R Zitnik; J Wines; M Kelley; S Rockwell
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

7.  VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.

Authors:  Andrew V Benest; Steven J Harper; Seppo Yla Herttuala; Kari Alitalo; David O Bates
Journal:  Cardiovasc Res       Date:  2007-12-07       Impact factor: 10.787

Review 8.  The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.

Authors:  Weon-Kyoo You; Donald M McDonald
Journal:  BMB Rep       Date:  2008-12-31       Impact factor: 4.778

Review 9.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis.

Authors:  F Silvagno; A Follenzi; M Arese; M Prat; E Giraudo; G Gaudino; G Camussi; P M Comoglio; F Bussolino
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

View more
  9 in total

Review 1.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

2.  Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts.

Authors:  Addolorata Corrado; Anna Neve; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2011-11-29       Impact factor: 3.984

Review 3.  Exploring the molecular role of endostatin in diabetic neuropathy.

Authors:  Tuhin Mukherjee; Tapan Behl; Aayush Sehgal; Saurabh Bhatia; Harmanpreet Singh; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-02-09       Impact factor: 2.316

Review 4.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

Review 5.  The 3D in vivo chorioallantoic membrane model and its role in breast cancer research.

Authors:  Cynthia Kohl; Thiha Aung; Silke Haerteis; Atanas Ignatov; Olaf Ortmann; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-05       Impact factor: 4.322

6.  Heparinized collagen scaffolds with and without growth factors for the repair of diaphragmatic hernia: construction and in vivo evaluation.

Authors:  Katrien M Brouwer; René M Wijnen; Daphne Reijnen; Theo G Hafmans; Willeke F Daamen; Toin H van Kuppevelt
Journal:  Organogenesis       Date:  2013-07-18       Impact factor: 2.500

7.  Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma.

Authors:  Miguel Angel Merlos Rodrigo; Hana Michalkova; Vladislav Strmiska; Berta Casar; Piero Crespo; Vivian de Los Rios; J Ignacio Casal; Yazan Haddad; Roman Guran; Tomas Eckschlager; Petra Pokorna; Zbynek Heger; Vojtech Adam
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

8.  Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications.

Authors:  Kevin T Campbell; Dustin J Hadley; David L Kukis; Eduardo A Silva
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

Review 9.  Therapeutic vascular growth in the heart.

Authors:  Ebba Brakenhielm; Vincent Richard
Journal:  Vasc Biol       Date:  2019-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.